- Bedoelde u
- mais diet
Zoekresultaten - 18 results
Epidemiologische surveillance van hantavirose- 2020
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Geebelen, Laurence; Melissa Depypere; Lize Cuypers; Piet Maes Source: (2021) Health Topics: Hantavirus ...
Surveillance épidémiologique de l’hantavirose- 2020
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Geebelen, Laurence; Melissa Depypere; Lize Cuypers; Piet Maes Source: (2021) Health Topics: Hantavirose ...
Surveillance épidémiologique de l’hantavirose- 2019
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Geebelen, Laurence; Melissa Depypere; Lize Cuypers; Piet Maes Source: (2021) Health Topics: Hantavirose ...
Epidemiologische surveillance van hantavirose- 2019
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Geebelen, Laurence; Melissa Depypere; Lize Cuypers; Piet Maes Source: (2021) Health Topics: Hantavirus ...
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
Maillart; Sarah Loof; Lucie Seyler; Martial Moonen; Moutschen, Michel; Niels Van Regenmortel; Ariën, Kevin K; Cyril Barbezange; Albrecht Betrains; Mutien Garigliany; Matthias M Engelen; Iwein Gyselinck; Piet ...
Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study
Publication Type: Peer reviewed scientific article Authors: Stefanie Desmet; Lagrou, Katrien; Chloé Wyndham-Thomas; Toon Braeye; Verhaegen, Jan; Piet Maes; Steffen Fieuws; Willy E Peetermans; ...
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial.
Dauby; Desmecht, Daniel; David Grimaldi; Bart N Lambrecht; Anne Luyten; Piet Maes; Moutschen, Michel; Marta Romano; Seyler, Lucie; Nevessignsky, Michel Toungouz; Katleen Vandenberghe; Johan van Griensven; ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Dauby; Desmecht, Daniel; David Grimaldi; Bart N Lambrecht; Anne Luyten; Piet Maes; Moutschen, Michel; Marta Romano; Lucie Seyler; Nevessignsky, Michel Toungouz; Katleen Vandenberghe; Johan Van Griensven; ...